"Does Insurance for Treatment Crowd Out Prevention? Evidence from Diabetics' Insulin Usage"
(New Version Coming Soon)
Abstract: I provide new evidence that health insurance can discourage investment in health. I find that, in the United States before 2006, 13-30% of female diabetics who used insulin to manage their condition stopped using insulin once they turned 65 and became eligible for health insurance via Medicare. I reconcile these results with those from other studies by developing a model of the trade-off between prevention and treatment. The model explains the large effect sizes in this paper via two mechanisms. First, individuals substitute prevention efforts away from periods when the price of treatment is low and toward periods when the price of treatment is high. Second, this effect is stronger for preventive measures that have larger effects on health. The model also shows that the long-term crowding out of prevention is at least as large as the shift in the timing of prevention estimated in this paper. The introduction of more generous subsidies for insulin under Medicare Part D in 2006 eliminated this effect, saving up to $487 million per annum in forgone health care costs.
Work in Progress
"Going Off-Script: Physician Licence Suspension and Health Outcomes for Medicaid Patients" (with Emma Boswell Dean and Mallick Hossain)
"Honest Inference for Discrete Outcomes" (with Walter Beckert)
"Shelter from the Storm? The Effect of Housing Wealth Shocks on the Demand for Prevention and Insurance" (with Gregory S. Burge and Lingxiao Zhao)
"Nonparametric Evidence on the Effect of Short-Term Subjective Medical Expenses Risk on Savings"